Middle East Medical Portal (MEMP) Board
NATHAN NAGEL – CEO
Mr Nathan Nagel is a serial entrepreneur with 21 years’ experience on the commercial side of medicine. In addition to being CEO of MEMP he has a portfolio of current board advisory positions in biotechnology and AI healthtech companies. His executive experience includes CEO at Gamlen Tableting Ltd, Board Adviser at the Mayfair Biohub Ltd, Interim Managing Director of the US liver disease CRO Sanyal Bio LLC, interim CEO of the neuroscience biotechnology company Neuro-Bio Ltd and CEO of the market research company Oncology Pharma Ltd. In parallel to leading Oncology Pharma Ltd Nathan was managing partner of LifeScience Ventures Ltd, a UK consulting company. Prior to leading companies Nathan worked for Bayer Diagnostics and Takeda Pharmaceuticals, where he started his career. Nathan lives in London, Dubai and extensively travels across the Middle East.
ANNA HASEDZIC – CHIEF OPERATIONS OFFICER
Mrs Anna-Lisa Hasedžić has over 20 years’ marketing and operations experience in a variety of sectors including I.T, finance, and NGO’s. She is an efficient, organised, and creative professional who manages the Middle East Medical Portal’s online operations. Anna-Lisa has a BSc (Hons) degree and Chartered Institute of Marketing (CMI) Professional Marketing Diploma.
ALISON MAGNALL – DIRECTOR OF CME
Mrs Alison Magnall trained and worked in the NHS. Her career in the UAE spans ten years in regulatory entities in Abu Dhabi and Dubai and her main focus has been on Legislation, Regulation, Accreditation, Governance, Compliance and Policy. Alison is currently an associate lecturer at Murdoch University Dubai teaching Bioethics and Law for healthcare in the postgraduate programme. She has kept in touch with her NHS roots through regular work in the UK. Alison also has a degree in English Language and Literature from Oxford University.
DR JULIAN STONE – BOARD ADVISER
Dr Julian Stone is a healthcare executive and serves on the board of several medical technology businesses. He has 30 years’ commercial experience with 20 years in medical technology, software, hardware, big data, and analytics. Dr Stone has led teams in both SME’S and multibillion-dollar corporates and has invested and mentored a wide variety of medical technology businesses. He holds a DBA and MBA. Dr Stone extensively travels across the Middle East.
MR NICK CLAXTON – BOARD ADVISER
Nick Claxton is a globally experienced commercial leader within the life sciences, biotech, and medical market sectors. His last 4 years have been working in the Middle East successfully establishing distributor networks. Mr Claxton has led teams within large blue-chip international organisations such as Becton Dickinson, Roche and Olympus, and SMEs. Mr Claxton has successfully managed mergers, acquisitions, and divestitures and has deep experience in change management after corporate transitions. Having had responsibility for the commercial part of the organisations, he has also directed technical and scientific teams due to his scientific background. Mr Claxton is Harvard University educated.